Investment Rating - The report maintains a "Strong Buy" rating for the company, expecting it to outperform the benchmark index by over 20% in the next six months [1][13]. Core Insights - The company reported a revenue of 1.71 billion yuan and a net profit of 180 million yuan for 2024, showing a year-on-year revenue decline of 1.8% but a net profit increase of 8.0%. In Q1 2025, the revenue was 360 million yuan, with a significant decline in net profit by 75.0% year-on-year [1][3]. - The company is a leader in the domestic aseptic packaging market, with a market share of approximately 10.5% in the Chinese aseptic packaging sales volume and 13.4% in the liquid milk market. The core customer, Yili, experienced a revenue decline of 8.2% in 2024 [1][7]. - The gross margin improved to 23.8% in 2024, up by 2.1 percentage points year-on-year, while the net profit margin also increased to 10.8% [1][7]. Financial Summary - For 2024, the company achieved total revenue of 1,706 million yuan, with a projected growth of 3.4% in 2025, reaching 1,764 million yuan. The net profit is expected to grow by 14.9% in 2025, reaching 211 million yuan [3][8]. - The earnings per share (EPS) for 2024 is projected at 0.44 yuan, with a price-to-earnings (P/E) ratio of 22. The target price is set at 11.7 yuan, compared to the current price of 9.69 yuan [3][8]. - The company’s total assets are projected to grow from 3.58 billion yuan in 2024 to 4.20 billion yuan by 2027, indicating a steady growth trajectory [8].

Core Viewpoint - The company reported a slight decline in revenue for 2024, but an increase in net profit, indicating a mixed performance amidst market challenges [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.71 billion, net profit of 180 million, and net profit excluding non-recurring items of 160 million, with year-on-year changes of -1.8%, +8.0%, and -4.2% respectively [1]. - For Q1 2025, the company reported revenue of 360 million, net profit of 10 million, and net profit excluding non-recurring items of 10 million, reflecting year-on-year declines of -18.2%, -75.0%, and -74.5% respectively [1]. Market Dynamics - The liquid milk market is contracting, impacting the company's liquid milk packaging revenue, which was 1.67 billion in 2024, down 1.1% year-on-year [2]. - The non-carbonated soft drink packaging revenue fell significantly by 35.4% to 30 million in 2024, compared to a growth of 45.3% in the same period of the previous year [2]. - The total packaging volume for 2024 was 12.08 billion units, a decrease of 1.4% year-on-year, with the company holding a 10.5% share of the Chinese aseptic packaging market and a 13.4% share in the liquid milk packaging segment [2]. Profitability and Cost Management - The company improved its gross margin to 23.8% in 2024, an increase of 2.1 percentage points year-on-year, while the net profit margin reached 10.8%, up 1.0 percentage points [3]. - In Q1 2025, the gross margin was 25.2%, reflecting a year-on-year increase of 2.7 percentage points, although it decreased slightly by 0.2 percentage points from the previous quarter [3]. - The company experienced fluctuations in expense ratios, with selling, administrative, and financial expense ratios reported at 3.5%, 8.1%, and 5.8% respectively for Q1 2025, with significant increases in financial expenses due to acquisition loan interest [3]. Strategic Outlook - The company has become the largest shareholder of Fenmei Packaging, which is expected to enhance synergies in capacity, research and development, and customer relations, potentially increasing market share [2]. - The company anticipates that the core client, Yili, will see a positive revenue trend in Q1 2025, which may further support growth [3].

Investment Rating - The report maintains a "Strong Buy" rating for the company, expecting it to outperform the benchmark index by over 20% in the next six months [7][13]. Core Views - The company reported a revenue of 1.71 billion yuan and a net profit of 180 million yuan for 2024, showing a year-on-year revenue decline of 1.8% but a net profit increase of 8.0%. For Q1 2025, the revenue was 360 million yuan, with a significant decline in net profit by 75.0% year-on-year [1][3]. - The company is positioned as a leader in the domestic aseptic packaging market, with a notable market share of approximately 10.5% in the Chinese aseptic packaging sales volume and 13.4% in the liquid milk market [7][8]. - The gross margin improved to 23.8% in 2024, up by 2.1 percentage points year-on-year, while the net profit margin also increased to 10.8% [7][8]. - The company anticipates synergies from the acquisition of Fenmei Packaging, which is expected to enhance its production capacity, research and development, and customer base [7][8]. Financial Summary - For 2024, the company achieved total revenue of 1,706 million yuan, with projected growth rates of 3.4%, 6.3%, and 7.3% for 2025, 2026, and 2027 respectively [3][8]. - The net profit for 2024 was 184 million yuan, with expected growth rates of 14.9%, 7.1%, and 7.5% for the following years [3][8]. - The earnings per share (EPS) for 2024 is projected at 0.44 yuan, with a price-to-earnings (P/E) ratio of 22 [3][8]. - The target price for the company's stock is set at 11.7 yuan, compared to the current price of 9.69 yuan [3][8].